Ozempic 1 mg solution for injection in pre-filled pen, Semaglutide Placebo, Ozempic 0.5 mg solution for injection in pre-filled pen, Ozempic 0.25 mg solution for injection in pre-filled pen
NN6535-7519
Phase 3 small_molecule active
Quick answer
Ozempic 1 mg solution for injection in pre-filled pen, Semaglutide Placebo, Ozempic 0.5 mg solution for injection in pre-filled pen, Ozempic 0.25 mg solution for injection in pre-filled pen for Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active